Drug name - Canasa

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8436051 ALLERGAN Mesalamine suppository Jun, 2028

(5 years from now)

US8217083 ALLERGAN Mesalamine suppository Jun, 2028

(5 years from now)

Drugs and Companies using MESALAMINE ingredient

Treatment: NA

Dosage: SUPPOSITORY;RECTAL

More Information on Dosage
Strength Dosage Availability
1GM SUPPOSITORY;RECTAL Prescription
500MG SUPPOSITORY;RECTAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.